Baricinix 4 mg and 2 mg , powered by Baricitinib , is a breakthrough oral medication used to treat moderate to severe Therapy for rheumatoid arthritis and COVID-19 complications in certain hospitalized patients. As a Janus kinase (JAK) inhibitor, Baricinix targets specific enzymes that cause inflammation in autoimmune diseases like rheumatoid arthritis. It has recently been approved for managing severe…
Tofacinix 5 mg (Tofacitinib) is an advanced oral medication used to treat rheumatoid arthritis (RA) and psoriatic arthritis. (PsA), and ulcerative colitis (UC). Tofacitinib, the active ingredient in Tofacinix, is a Janus kinase (JAK) inhibitor that targets the immune system to reduce inflammation and alleviate the symptoms of autoimmune conditions. It is a versatile treatment option for patients who have…
